Sono-Tek Corporation — Form 10-K Summary
Reporting period: Fiscal year ended February 28, 2017, compared with the year ended February 29, 2016. Sono-Tek develops and sells ultrasonic spray-coating equipment and services; it reports ultrasonic spraying and real estate operations as segments.
Financial performance
| Metric | FY2017 | FY2016 |
|---|---|---|
| Consolidated net sales | $9.725 million | $11.834 million |
| Gross profit | $4.494 million | $5.638 million |
| Gross margin | 46.2% | 47.6% |
| Operating income (loss) | $(148,000) | $740,000 |
| Net income | $96,000 | $548,000 |
| Basic and diluted EPS | $0.01 | $0.04 |
| Cash from operating activities | $1.029 million | $629,000 |
| Cash and cash equivalents | $2.557 million | $2.388 million |
| Marketable securities | $2.342 million | $1.696 million |
| Total debt | $1.176 million | $1.320 million |
Consolidated sales declined about 18%, and gross margin fell about 1.4 percentage points. Operating margin shifted from approximately 6.3% to negative 1.5%; net margin fell from approximately 4.6% to 1.0%. Working capital rose to $6.385 million from $5.855 million, and the current ratio improved to 5.4 from 4.5. Cash plus marketable securities totaled $4.899 million, up $815,000. Investing activities used $716,000, including $183,000 for equipment and $534,000 for marketable securities; financing activities used $143,000 for debt repayment.
Material changes and business drivers
- Management attributed the sales decline largely to weaker demand for WideTrack glass-coating systems: sales of those units fell $1.615 million. Declines in nozzles and generators, PCB fluxers, and stent-coating units also weighed on results.
- XYZ platform sales increased $509,000, partially offsetting declines. The company introduced its ALIGN integrated spray module during FY2017.
- Ultrasonic spraying segment sales were $9.635 million, down 18%; segment gross margin was 46%, versus 47%. Segment operating loss was $78,000, compared with $804,000 of operating income a year earlier.
- Exports were $5.361 million, down 18%, but remained 56% of revenue. Western Europe sales declined 36% and Far East sales declined 8%.
- Research and product development spending was approximately $1.250 million, little changed from FY2016.
Liquidity, debt, and unusual items
- The company had no borrowings on its $750,000 revolving credit line at year-end. The line is payable on demand, secured by company assets other than land and buildings, and must be paid down for 30 days once annually.
- Mortgage debt of $1.176 million bears interest at 4.15% and is secured by the company’s land and buildings. The filing reports $149,698 due within one year.
- FY2017 other income included a $200,000 life-insurance payout following the death of a former employee. The company also recorded a $19,000 income-tax benefit, compared with $195,000 of tax expense in FY2016.
- Unrealized gains on available-for-sale securities were $112,000 for the year, leaving accumulated other comprehensive income of $42,250 at year-end. Management said it did not consider the investment valuation changes other-than-temporary.
- The real estate segment reported a $123,000 net loss and $192,000 net cash outflow. The filing says leasing additional vacant space could improve property cash flow.
Outlook, risks, and other disclosures
The filing provides no specific revenue or earnings guidance. Management described its expanded product range, markets, and geographic reach as a foundation for future growth and profitability, while noting that results depend on sales growth, product development and acceptance, financing, competition, and economic, political, regulatory, and technological conditions. The company serves six industries and relies on international markets and distributors; foreign customers accounted for 56% of revenue. One customer represented 7% of sales, while six customers accounted for 46% of year-end receivables.
The company reported no material commitments or contingencies, no legal proceedings, and no off-balance-sheet arrangements. It had $77,543 of cash at a foreign bank pledged for customer-related guarantees, which expire at various dates in 2017. Management concluded disclosure controls and internal control over financial reporting were effective as of year-end. The independent auditor issued an unqualified opinion on the financial statements.
Important facts for investors to verify
- Confirm the extent to which lower WideTrack demand and other product declines continued after FY2017, and whether the XYZ platform and ALIGN product generated sustained growth.
- Assess earnings quality: reported net income included the $200,000 insurance proceeds, while operating activities generated $1.029 million of cash.
- Review inventory valuation and demand: net inventory fell to $1.341 million, while the inventory allowance increased to $255,000 from $175,000.
- Evaluate international exposure, export trends, customer concentration, and the $77,543 of cash pledged for guarantees.
- Reconcile presentation differences: MD&A gives consolidated net sales of $9.725 million and ultrasonic segment sales of $9.635 million; it separately cites an ultrasonic-segment gross profit of $4.404 million, whereas the audited consolidated statements report gross profit of $4.494 million.